We are live on ! Find out more

478 hedge funds and large institutions have $7.61B invested in Sanofi in 2018 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 133 increasing their positions, 181 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

347% more call options, than puts

Call options by funds: $51.2M | Put options by funds: $11.5M

43% more funds holding in top 10

Funds holding in top 10: 710 (+3)

5% less first-time investments, than exits

New positions opened: 52 | Existing positions closed: 55

1.8% less ownership

Funds ownership: 16.96%15.15% (-1.8%)

2% less funds holding

Funds holding: 487478 (-9)

11% less capital invested

Capital invested by funds: $8.52B → $7.61B (-$915M)

27% less repeat investments, than reductions

Existing positions increased: 133 | Existing positions reduced: 181

Holders
478
Holders Change
-9
Holders Change %
-1.85%
% of All Funds
10.9%
Holding in Top 10
10
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+42.86%
% of All Funds
0.23%
New
52
Increased
133
Reduced
181
Closed
55
Calls
$51.2M
Puts
$11.5M
Net Calls
+$39.8M
Net Calls Change
+$4.54M

SNY Hedge Fund Activity: Q2 2018 in Review

478 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q2 2018, worth a combined $7.61B — down 11% from $8.52B a quarter earlier.

Sellers outnumbered buyers: 55 funds closed out of SNY and 52 opened new positions — a net loss of 3 holders — while 181 trimmed existing stakes and 133 added.

The largest buyer was Fisher Asset Management, adding an estimated $21.6M. The largest seller was Franklin Resources, cutting an estimated $713M.

  • 478 institutional investors held Sanofi (SNY) as of Q2 2018, down from 487 in Q1 2018.
  • Funds reported $7.61B of Sanofi stock for Q2 2018, down 11% quarter-over-quarter.
  • 52 funds opened new Sanofi positions in Q2 2018 and 55 closed out, a net change of -3 holders.
  • The largest Sanofi buyer in Q2 2018 was Fisher Asset Management, an estimated $21.6M added.
  • The largest Sanofi seller in Q2 2018 was Franklin Resources, an estimated $713M sold.

Based on aggregated 13F filings for Q2 2018.